Other Neuropsychiatric Disorders & General Information

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3! - Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis

Viktória Simon, Pál Czobor, Sára Bálint, Ágnes Mészáros, and István Bitter

The British Journal of Psychiatry (2009) 194: 204-211

 

5 - Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder

Lenard A. Adler, Michael Liebowitz, William Kronenberger, Meihua Qiao, Richard Rubin, Millie Hollandbeck, Ahmed Deldar, Kory Schuh, Todd Durell

Depression and Anxiety. Volume 26 Issue 3, Pages 212 - 221

 

3 - Atypical Antipsychotic Quetiapine in the Management of Severe Refractory Functional Gastrointestinal Disorders

Original Article

Atypical Antipsychotic Quetiapine in the Management of Severe Refractory Functional Gastrointestinal Disorders

Madhusudan Grover, Spencer D. Dorn, Stephan R. Weinland, Christine B. Dalton, Bradley N. Gaynes and Douglas A. Drossman

Digestive Diseases and Sciences. On Line First. March 2009

 

3 - László Meduna's Pilot Studies With Camphor Inductions of Seizures: The First 11 Patients

Gazdag, Gábor; Bitter, István; Ungvari, Gabor S; Baran, Brigitta; Fink, Max

The Journal of ECT:Volume 25(1)March 2009pp 3-11

 

3 - Mg²⁺ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine

Shawn E. Kotermanski and Jon W. Johnson

The Journal of Neuroscience, March 4, 2009, 29(9):2774-2779

 

GRATIS 3! - Systematic Reviews of Genetic Association Studies

Sagoo GS, Little J, Higgins JPT

PLoS Med 2009; 6(3): e1000028

 

3! - Contribution of Vascular Risk Factors to the Progression in Alzheimer Disease

Elizabeth P. Helzner, José A. Luchsinger, Nikolaos Scarmeas, Stephanie Cosentino, Adam M. Brickman, M. Maria Glymour, Yaakov Stern

Arch Neurol. 2009;66(3):343-348

 

3! - Midlife and Late-Life Obesity and the Risk of Dementia. Cardiovascular Health Study

Annette L. Fitzpatrick, Lewis H. Kuller, Oscar L. Lopez, Paula Diehr, Ellen S. O’Meara, W. T. Longstreth Jr, José A. Luchsinger

Arch Neurol. 2009;66(3):336-342

 

5 - A controlled trial of antidepressants in patients with Parkinson disease and depression

M. Menza, R. D. Dobkin, H. Marin, M. H. Mark, M. Gara, S. Buyske, K. Bienfait, and A. Dicke

NEUROLOGY 2009;72:886-892

GRATIS 3 - Update on the use of memantine in Alzheimer’s disease

Robert J van Marum

Neuropsychiatric Disease and Treatment 2009:5 107–117

 

3! - Antidiabetic drug metformin (Glucophage^R) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription

Yaomin Chen, Kun Zhou, Ruishan Wang, Yun Liu, Young-Don Kwak, Tao Ma, Robert C. Thompson, Yongbo Zhao, Layton Smith, Laura Gasparini, Zhijun Luo, Huaxi Xu and Francesca-Fang Liao

PNAS March 10, 2009 vol. 106 no. 10 3907-3912

 

3 - Predicting response to acetylcholinesterase inhibitor treatment in Alzheimer disease: has the time come?

Howard H Feldman and Claudia Jacova

Nature Clinical Practice Neurology (2009) 5, 128-129

5 - A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist, Naltrexone, in the Treatment of Kleptomania

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jon E. Grant, Suck Won Kim and Brian L. Odlaug

Biological Psychiatry. Volume 65, Issue 7, 1 April 2009, Pages 600-606

5< - Methylphenidate Restores Link Between Stop-Signal Sensory Impact and Successful Stopping in Adults with Attention-Deficit/Hyperactivity Disorder

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Carin C.E. Overtoom, Evelijne M. Bekker, Maurits W. van der Molen, Marinus N. Verbaten, J.J. Sandra Kooij, Jan K. Buitelaar and J. Leon Kenemans

Biological Psychiatry. Volume 65, Issue 7, 1 April 2009, Pages 614-619

4 - Increase of BDNF Serum Concentration in Lithium Treated Patients with Early Alzheimer's Disease

Thomas Leyhe, Gerhard W. Eschweiler, Elke Stransky, Thomas Gasser, Peter Annas, Hans Basun, Christoph Laske

Journal of Alzheimer's Disease. Volume 16, Number 3 / 2009: 649-656

 

3 - Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis

David R Janero & Alexandros Makriyannis

Expert Opinion on Emerging Drugs. March 2009, Vol. 14, No. 1, Pages 43-65

 

3 - Empirical Evidence for the Use of Anticonvulsants in Personality Disorders

M. Sieberer, H. M. Emrich

Fortschr Neurol Psychiatr 2009; 77: 133-138

 

3! - Neuroleptic Malignant Syndrome in Traumatic Brain Injury Patients Treated With Haloperidol

Bellamy, Cassandra J; Kane-Gill, Sandra L; Falcione, Bonnie A; Seybert, Amy L

The Journal of Trauma: Injury, Infection, and Critical Care:Volume 66(3)March 2009pp 954-958

 

3 - Safety and Subjective Sleep Effects of Ramelteon Administration in Adults and Older Adults With Chronic Primary Insomnia: A 1-Year, Open-Label Study

Gary S. Richardson, Gary Zammit, Sherry Wang-Weigand, and Jeffrey Zhang

J Clin Psychiatry March 10, 2009: e1-e10

 

3 - Use and misuse of antipsychotic drugs in patients with dementia in Alzheimer special care units

Nobili, Alessandro; Pasina, Luca; Trevisan, Silvia; Riva, Emma; Lucca, Ugo; Tettamanti, Mauro; Matucci, Marina; Tarantola, Massimo

International Clinical Psychopharmacology: March 2009 - Volume 24 - Issue 2 - pp 97-104

 

3 - The cortical signature of prodromal AD. Regional thinning predicts mild AD dementia

Akram Bakkour, John C. Morris, and Bradford C. Dickerson

NEUROLOGY 2009;72:1048-1055

3 - CSF biomarkers in relationship to cognitive profiles in Alzheimer disease

A. E. van der Vlies, N. A. Verwey, F. H. Bouwman, M. A. Blankenstein, M. Klein, P. Scheltens, and W. M. van der Flier

NEUROLOGY 2009;72:1056-1061

3! - The Prognostic Impact of Psychotropic Drugs in Intentional Drug Overdose

M. Tournier, A. Grolleau, A. Cougnard, H. Verdoux, M. Molimard

Pharmacopsychiatry 2009; 42: 51-56

3 - Visual Hallucinations in Dementia: A Prospective Community-Based Study With Autopsy

Tsuang, Debby; Larson, Eric B; Bolen, Elizabeth; Thompson, Mary Lou; Peskind, Elaine; Bowen, James; McCormick, Wayne; Teri, Linda; Kukull, Walter; Vavrek, Darcy; Montine, Thomas; Leverenz, James B

American Journal of Geriatric Psychiatry: April 2009 - Volume 17 - Issue 4 - pp 317-323

 

3! - Neurobiological Mechanisms of Placebo Responses

Jon-Kar Zubieta and Christian S. Stohler

Annals of the New York Academy of Sciences. Volume 1156; 2009, Pages 198 - 210

 

3! - The Role of Sleep in Cognition and Emotion

Matthew P. Walker

Annals of the New York Academy of Sciences. Volume 1156; 2009, Pages 168 - 197

 

3! - Leptin, ghrelin, and endocannabinoids: Potential therapeutic targets in anorexia nervosa

References and further reading may be available for this article. To view references and further reading you must purchase this article.

René Klinkby Støving, Alin Andries, Kim Brixen, Allan Flyvbjerg, Kirsten Hørder and Jan Frystyk

Journal of Psychiatric Research. Volume 43, Issue 7, April 2009, Pages 671-679

 

3 - Decreased Activation Along the Dorsal Visual Pathway After a 3-Month Treatment With Galantamine in Mild Alzheimer Disease: A Functional Magnetic Resonance Imaging Study

Bokde, Arun LW; Karmann, Michaela; Teipel, Stefan J; Born, Christine; Lieb, Martin; Reiser, Maximilian F; Möller, Hans-Jürgen; Hampel, Harald

Journal of Clinical Psychopharmacology: April 2009 - Volume 29 - Issue 2 - pp 147-156

 

5< - Clonidine Improves Hyperarousal in Borderline Personality Disorder With or Without Comorbid Posttraumatic Stress Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Ziegenhorn, Andreas A; Roepke, Stefan; Schommer, Nicole C; Merkl, Angela; Danker-Hopfe, Heidi; Perschel, Frank H; Heuser, Isabella; Anghelescu, Ion G; Lammers, Claas H

Journal of Clinical Psychopharmacology: April 2009 - Volume 29 - Issue 2 - pp 170-173

 

GRATIS 3 - Update on the use of memantine in Alzheimer’s disease

Robert J van Marum

Neuropsychiatric Disease and Treatment. March 2009

 

3 - Critical Issues for Successful Immunotherapy in Alzheimer’s Disease: Development of Biomarkers and Methods for Early Detection and Intervention 
Rawan Tarawneh and David M. Holtzman

CNS & Neurological Disorders - Drug Targets. Volume 8, Number 2, April 2009: 144-159

 

3! - Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
Bruno Vellas, R. Black, Leon J. Thal, Nick C. Fox, M. Daniels, G. McLennan, C. Tompkins, C. Leibman, M. Pomfret, Michael Grundman; for the AN1792 (QS-21)-251 Study Team

Current Alzheimer Research. Volume 6, Number 2, April 2009: 114-151

 

GRATIS 3 - Advances in Alzheimer Therapy: Understanding Pharmacological Approaches to the Disease
Ana Martínez, Debomoy K. Lahiri, Ezio Giacobini and Nigel H. Greig

Current Alzheimer Research. Volume 6, Number 2, April 2009: 83-85

 

3 - Cholinesterase Inhibitors and Beyond
Giancarlo Pepeu and Maria Grazia Giovannini

Current Alzheimer Research. Volume 6, Number 2, April 2009: 86-96

 

3 - Responders to ChEI Treatment of Alzheimer’s Disease Show Restitution of Normal Regional Cortical Activation
Annalena Venneri, William J. McGeown and Michael F. Shanks

Current Alzheimer Research. Volume 6, Number 2, April 2009: 97-111

 

3 - GEPT Extract Reduces Aβ Deposition by Regulating the Balance Between Production and Degradation of Aβ in APPV717I Transgenic Mice
Jinzhou Tian, Jing Shi, Leiming Zhang, Junxiang Yin, Quan Hu, Yi Xu, Shuli Sheng, Pengwen Wang, Ying Ren, Rong Wang and Yongyan Wang

Current Alzheimer Research. Volume 6, Number 2, April 2009: 118-131

 

GRATIS 3 - Depression in Parkinson’s disease: clinical-epidemiological correlates and comparison with a controlled group of non-parkinsonian geriatric patients

Beatriz Azevedo dos Anjos Godke Veiga, Vanderci Borges, Sonia Maria César de Azevedo Silva, Fabrício de Oliveira Goulart, Maysa Seabra Cendoroglo, Henrique Ballalai Ferraz

Rev Bras Psiquiatr. 2009;31(1):39-42

.

Regresar a RESÚMENES MARZO 2009